JPWO2021020362A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021020362A5
JPWO2021020362A5 JP2021535340A JP2021535340A JPWO2021020362A5 JP WO2021020362 A5 JPWO2021020362 A5 JP WO2021020362A5 JP 2021535340 A JP2021535340 A JP 2021535340A JP 2021535340 A JP2021535340 A JP 2021535340A JP WO2021020362 A5 JPWO2021020362 A5 JP WO2021020362A5
Authority
JP
Japan
Prior art keywords
group
hydrogen atom
substituent
ring
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021535340A
Other languages
English (en)
Japanese (ja)
Other versions
JP7636326B2 (ja
JPWO2021020362A1 (cg-RX-API-DMAC7.html
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2020/028784 external-priority patent/WO2021020362A1/ja
Publication of JPWO2021020362A1 publication Critical patent/JPWO2021020362A1/ja
Publication of JPWO2021020362A5 publication Critical patent/JPWO2021020362A5/ja
Application granted granted Critical
Publication of JP7636326B2 publication Critical patent/JP7636326B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021535340A 2019-07-29 2020-07-28 複素環化合物 Active JP7636326B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019139174 2019-07-29
JP2019139174 2019-07-29
PCT/JP2020/028784 WO2021020362A1 (ja) 2019-07-29 2020-07-28 複素環化合物

Publications (3)

Publication Number Publication Date
JPWO2021020362A1 JPWO2021020362A1 (cg-RX-API-DMAC7.html) 2021-02-04
JPWO2021020362A5 true JPWO2021020362A5 (cg-RX-API-DMAC7.html) 2023-07-03
JP7636326B2 JP7636326B2 (ja) 2025-02-26

Family

ID=74228459

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021535340A Active JP7636326B2 (ja) 2019-07-29 2020-07-28 複素環化合物

Country Status (4)

Country Link
US (1) US20220289679A1 (cg-RX-API-DMAC7.html)
EP (1) EP4005637A4 (cg-RX-API-DMAC7.html)
JP (1) JP7636326B2 (cg-RX-API-DMAC7.html)
WO (1) WO2021020362A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021020363A1 (ja) 2019-07-29 2021-02-04 武田薬品工業株式会社 複素環化合物
CN115925618A (zh) * 2023-01-06 2023-04-07 河南省科学院化学研究所有限公司 一种2-(2,2,2-三氟乙氧基)-6-氯-3-氨基吡啶的合成方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050288290A1 (en) 2004-06-28 2005-12-29 Borzilleri Robert M Fused heterocyclic kinase inhibitors
US7439246B2 (en) 2004-06-28 2008-10-21 Bristol-Myers Squibb Company Fused heterocyclic kinase inhibitors
JO2787B1 (en) * 2005-04-27 2014-03-15 امجين إنك, Alternative amide derivatives and methods of use
US7723330B2 (en) 2006-03-07 2010-05-25 Array Biopharma Inc. Heterobicyclic pyrazole compounds and methods of use
JPWO2009096435A1 (ja) * 2008-01-29 2011-05-26 武田薬品工業株式会社 縮合複素環誘導体およびその用途
US8445509B2 (en) 2008-05-08 2013-05-21 Takeda Pharmaceutical Company Limited Fused heterocyclic derivatives and use thereof
SG10201401836RA (en) * 2009-04-27 2014-10-30 Elan Pharm Inc Pyridinone antagonists of alpha-4 integrins
WO2012004217A1 (en) * 2010-07-06 2012-01-12 Novartis Ag Cyclic ether compounds useful as kinase inhibitors
EP2562174A1 (de) * 2011-08-24 2013-02-27 Bayer Cropscience AG Herbizid wirksame 6-Oxo-1,6-dihydropyrimidin-5-carboxamide und 2-Oxo-1,2-dihydropyridin-3-carboxamide
UY34686A (es) * 2012-03-20 2013-10-31 Syngenta Ltd ?compuestos herbicidas, sus usos, composiciones que los contienen y método para controlar malezas?.
MA37975B2 (fr) 2012-09-11 2021-03-31 Genzyme Corp Inhibiteurs de synthase de glucosylcéramide
EP3067356B1 (en) * 2013-11-08 2018-07-04 ONO Pharmaceutical Co., Ltd. Pyrrolo pyrimidine derivative
EP3079695B1 (en) 2013-12-11 2021-03-17 Genzyme Corporation Glucosylceramide synthase inhibitors
CN106279147A (zh) * 2015-05-21 2017-01-04 中国科学院上海药物研究所 一种吡啶并氮杂环化合物及其制备方法和用途
TWI828027B (zh) * 2016-03-28 2024-01-01 美商英塞特公司 作為tam抑制劑之吡咯并三嗪化合物
SG11201810366WA (en) 2016-05-25 2018-12-28 Bayer Pharma AG 3-oxo-2,6-diphenyl-2,3-dihydropyridazine-4-carboxamides
EP3747885A4 (en) 2018-01-31 2021-11-03 Takeda Pharmaceutical Company Limited HETEROCYCLIC COMPOUND
JP2019139174A (ja) 2018-02-15 2019-08-22 三菱製紙株式会社 電子写真記録材料

Similar Documents

Publication Publication Date Title
RU2353616C2 (ru) Производные 2-пиридона в качестве ингибиторов эластазы нейтрофилов и их применение
JP2008513515A5 (cg-RX-API-DMAC7.html)
JP2013509392A5 (cg-RX-API-DMAC7.html)
Bekhit et al. Synthesis and biological evaluation of some thiazolylpyrazole derivatives as dual anti-inflammatory antimicrobial agents
JP2022552444A5 (cg-RX-API-DMAC7.html)
JP2009516646A5 (cg-RX-API-DMAC7.html)
JP2011502958A5 (cg-RX-API-DMAC7.html)
JP2017502940A5 (cg-RX-API-DMAC7.html)
RU2019135891A (ru) ИНГИБИТОРЫ β-ЛАКТАМАЗ И ИХ ПРИМЕНЕНИЕ
JP2008513514A5 (cg-RX-API-DMAC7.html)
JP2019537594A5 (cg-RX-API-DMAC7.html)
JP2018536648A5 (cg-RX-API-DMAC7.html)
NO20053211L (no) Forbindelser for behandling av metabolske forstyrrelser.
JP2012533546A5 (cg-RX-API-DMAC7.html)
JPS5976067A (ja) ピペラジン誘導体の製造方法
JP2014507464A5 (cg-RX-API-DMAC7.html)
JP2013541596A5 (cg-RX-API-DMAC7.html)
JP2007519695A5 (cg-RX-API-DMAC7.html)
RU2013125338A (ru) Производные триазола в качестве лигандов рецепторов гамк
JP2008513485A5 (cg-RX-API-DMAC7.html)
JP2018536678A5 (cg-RX-API-DMAC7.html)
JP2018515489A5 (cg-RX-API-DMAC7.html)
JP2017500321A5 (cg-RX-API-DMAC7.html)
JP2010536750A5 (cg-RX-API-DMAC7.html)
JP2005529842A5 (cg-RX-API-DMAC7.html)